Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The Royal Wolverhampton Hospitals NHS Trust
Swiss Cancer Institute
Hutchmed
Isofol Medical AB
NSABP Foundation Inc
Eastern Cooperative Oncology Group
Amgen
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
SWOG Cancer Research Network
National Cancer Institute (NCI)
Norgine
Amgen
Alliance for Clinical Trials in Oncology
The Cleveland Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Braintree Laboratories
Braintree Laboratories
NSABP Foundation Inc
NSABP Foundation Inc
Massachusetts General Hospital